Curative Biotechnology Inc (CUBT)

[MarkDaShark]

I personally expect this to accumulate to the price of the drug plus the price of the PRV as news gets announced about stuff like university partnerships to do the clinical trials, along with other details (so around 1 dollar). If the trials are ran successfully, this shows the company knew it was doing and it will stabilize around the price, maybe dip. If the trials are run successfully and there is a positive result, 4-5x the value at least, perhaps more, considering they have an agreement to sell a cure to rabies, without FDA regulation or have a childhood brain cancer therapeutic that can be sold for tons of money (so around 5-10 dollars a share). Keep in mind this is at least 24 months out. This company has seemingly always been ahead of schedule, and Paul being experienced probably already has trial locations + dates in mind that he has through negotiate to with funders.

What's the odds of all this happening? Perfectly? 0. But at this price point its definitely worth the risk imo considering he has made these deals for a 100 billion dollar company.